Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the past week.
Insiders Are Loading Up on These 4 Biotech Stocks Now
view original post
Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the past week.